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Abstract—2,4-Disubstituted quinolines with additional substituents in positions 5-8 have been found to have anthelmintic properties.  A 
number of 2,4-dimethoxy-6- or 8-arylquinolines have potent activity against the sheep nematode Haemonchus contortus, with LD99 
values of the same order of magnitude as levamisole.  These arylquinolines maintain their activity against levamisole, ivermectin and 
thiabendazole resistant strains of H contortus.  ©2000 Elsevier Science Ltd. All rights reserved. 
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Parasitic nematode infections are a continuing threat in 
both human and animal medicine. The most commonly 
used classes of drugs to treat such infections are the 
benzimidazoles such as thiabendazole 1, imidazo-
thiazoles such as levamisole 2, and avermectins 
(obtained from the fermentation products of 
Streptomyces avermitilis). There is evidence of 
emerging resistance to some drugs in the developing 
world,1 and in some areas with high agricultural 
dependence multiple resistance to all of the major drug 
classes is appearing in livestock.2 Alternatives to these 
classes of drug are now being sought. 
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We recently published a concise synthesis of the 
prenylquinoline alkaloid atanine, 3,3 shown to be active 
against larval stages of the trematode parasite 
Schistosoma mansoni, the cause of schistosomiasis 
(bilharzia), a major health issue in developing 
countries.4   
As part of our program of synthesis and testing of novel 
atanine analogues, we synthesized a number of 
intermediate trisubstituted quinolines with substituents 
in ring positions 5-8. Tests against S. mansoni larval 
stages and the model nematode C. elegans revealed that 
some of these intermediates exhibited anti-nematode 
activity, differing from the pattern of activity against 
schistosomes.5   
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From these early biological results, we became 
interested in aryl-substituted quinolines, and so we set 
out to investigate the synthesis of these novel 2,4-
dimethoxy aryl-substituted quinolines by exploring the 
Suzuki coupling of 5-, 6-, 7- or 8-bromoquinoline 
intermediates. 
 
Substituted-2,4-dimethoxyquinolines were synthesized 
by condensation/cyclization of the appropriate 
substituted aniline 4 with malonic acid and phosphoryl 
chloride to give the 2,4-dichloroquinoline 5, followed 
 
by displacement by methoxide ion to give the required 
quinoline 6 (Scheme 1).6  
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Scheme 1. Synthesis of substituted-2,4-dimethoxy-quinolines 
 
For our proposed synthesis of arylquinolines, the 
bromoquinoline precursors were synthesized. 
Cyclization of 3-bromoaniline gave a mixture of the 5- 
and 7-bromoquinolines, which were separable by 
column chromatography.  
The bromo-2,4-dimethoxy-quinolines 7 were then 
coupled to the required aryl groups under Suzuki 
conditions to yield the arylquinolines 8 (scheme 2). 
These proceeded in good yield, although it was 
observed that 8-bromoquinolines were much more 
sensitive, requiring stricter oxygen-free reaction 
conditions to give consistent yields.8
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Scheme 2. Synthesis of arylquinolines via Suzuki coupling 
 
A number of 2,4-disubstituted quinolines (ca 80) were 
tested against the agriculturally important parasitic 
nematode Haemonchus contortus, using the commercial 
NemaTox larval development screen used for 
determining drug susceptibility.9  It was observed that 
greater than 40% of these compounds exhibited 
nematocidal activity (LD99 <100 µg/mL), with those 
exhibiting LD99 better than 25 µg/mL shown in Table 1. 
In particular, it appeared that 6- or 8-substituted 2,4-
dimethoxyquinolines showed the greatest activity 
against H. contortus. Five compounds, including the 
arylquinolines 13-16, had LD99 of 12.5 µg/mL or lower 
in this first screen, showing potential for useful anti-
nematode activity. The LD99 of compounds 15 and 16, 
3.1 µg/mL, was of the same order as the commercial 
nematocides levamisole and closantel. These five most 
active compounds were resynthesized in gram quantities 
for further investigation. 
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Table 1: LD99 values for compounds 9-16 (substituted at positions 2-8) against H. contortus 
 
Compound R2 R3 R4 R5 R6 R7 R8 LD99, µg/mL 
9a OMe Ph OMe H H H H 25 
10 OMe H OMe Me H Me H 25 
11b Cl H OMe H H H H 25 
12 OMe H OMe H Cl H H 12.5 
13 OMe H OMe H H H Ph 12.5 
14 OMe H OMe H H H 4-MeO-C6H4 12.5 
15 OMe H OMe H Ph H H 3.1 
16 OMe H OMe H 4-MeO-C6H4 H H 3.1 
a Synthesized from 2,4-dimethoxyquinoline by bromination at position 3 and subsequent Suzuki coupling.5, 10 
b Product of incomplete substitution of 2,4-dichloroquinoline by methoxide 
 
Table 2: LD99 values of compounds 12-16 against susceptible and drug-resistant nematodes 
 
 
LD99, µg/mL 
Compound 
H contortus 
susceptible 
H contortus 
VSRG, 
benzimidazole 
resistant 
H contortus Lawes, 
levamisole  and 
benzimidazole 
resistant 
H contortus 
CAVR, 
ivermectin 
resistant 
T colubriformis  O circumcincta  
12 13 13 8.8 6.3 25 13 
13 6.3 4.4 6.3 3.1 50 6.3 
14 6.3 6.3 3.1 3.1 6.3 3.1 
15 3.1 3.1 3.1 3.1 6.3 3.1 
16 3.1 2.2 1.6 1.6 3.1 3.1 
1 0.16 5 5 0.16 nt nt 
2 1.6 1.6 >100 0.78 nt nt 
nt: not tested 
 
 
Compounds 12-16 were tested against susceptible 
strains of H. contortus, strains resistant to 
benzothiazoles (VSRG strain), ivermectin (CAVR 
strain) or both benzothiazoles and levamisole (Lawes 
strain), plus susceptible strains of T colubriformis and 
O. circumcincta. Results are shown in Table 2, with 
activities of thiabendazole 1 and levamisole 2 for 
comparison.   
Of these compounds, 15 and 16 exhibited the greatest 
activity against susceptible strains of H. contortus 
(3.1µg/mL), comparable in potency to levamisole. 15 
and 16 were also potent against the various drug-
resistant strains of H contortus, with even improved 
activity for 16; LD99 1.6 µg/mL, against both the 
multiple-resistant Lawes strain and the ivermectin 
resistant CAVR strain. There is also evidence of 
activity against the important parasitic nematodes 
Trichostrongylus colubriformis and Ostertagia 
circumcincta. 
 
In summary, we have prepared novel arylquinolines in 
good yields via Suzuki coupling of substituted 
bromoquinolines. We have demonstrated that a 
number of these quinolines, in particular the 6-
arylquinolines 15, 16, show promising potency against 
susceptible and drug-resistant strains of an important 
nematode target, and represent a new class of 
anthelmintic compounds. There is obvious potential 
for lead optimization and further development to offer 
a new line of defence against drug-resistant parasitic 
nematode infections. 
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